Notice ID: 9bf4046e8a09849e4fa92577883aab11Special Notice
65--iFOB (Immuno Fecal Occult Blood) Cost Per Test and Instrumentation
Archived on September 20, 2019. Full description on SAM.gov.
Overview
- Posted
- August 21, 2019
- Notice type
- Special Notice
- NAICS
- 325413: In-Vitro Diagnostic Substance Manufacturing
Notice details
- PSC
- 65: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
- Last updated
- Dec 6, 2025
Identifiers
- Solicitation number
- 36C24819Q1404
- Notice ID
- 9bf4046e8a09849e4fa92577883aab11
Description
This is a notice of contract action (NOCA). This is not a solicitation for quotes. The purpose of this NOCA is to notify industry of the VA s intended contract action identify potential sources and their size and socioeconomic classifications. Network Contracting Office (NCO) 8 West Palm Beach intends to issue a sole source, firm fixed price contract under FAR Part 6.302, Circumstances Permitting Other Than Full and Open Competition, FAR part 12, Acquisition of Commercial Items, FAR part 13, Simplified Acquisition Procedures to Polymedco Cancer Diagnostic Products LLC to obtain instrumentation for cost per test services inclusive of all reagents and expendable supplies necessary to perform automated testing for occult blood in stool specimens using immunochemistry technology. The contract action is anticipated to be for a base year plus four option years with an estimated value of approximately $351,000. Vendors who believe they can meet the requirements should submit a capability statement, providing clear and convincing evidence documenting their ability to provide the requirements of this acquisition. All information shall be in writing, containing sufficient detail to allow the government to evaluate and determine if it can meet their needs. All responses must be submitted via email to the Contracting Officer at Deborah.Murphy3@va.gov received no later than 12:00 PM EST, August 30, 2019. No reimbursement will be made for any costs associated with providing information in response to this NOCA or any follow-up information requests.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
36C24819Q1404- Special NoticeCurrentAug 21, 2019
65--iFOB (Immuno Fecal Occult Blood) Cost Per Test and Instrumentation
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
| - | Solicitation | 11/04/2016 | |
Combined synopsis/solicitation for Immunoassay Reagents, Supplies and Consumables to be used for patient testing on an existing Architect i1000 analyzer located at the Pathology and Laboratory Medicine Services in Southern Arizona VA Medical Center (VA Tucson). | - | Combined Synopsis | 11/13/2026 |
Boise, Idaho VAMC Transfusion Services requires red blood cell reagents that meet strict quality control and compliance standards for patient testing. These reagents are essential for safely matching donated blood products to recipients who need them for life-saving treatments—a process carried out exclusively in the Transfusion Services Department. The vendor is responsible for supplying quality control check cells as well as antibody identification panel cells to fulfill these requirements and support effective patient care. 5-year agreement. Base Year Period of Performance: 12/01/2026-11/30/2027. Four option years to follow based upon the Government's needs and discretion. Transfusion Medicine supports all major hospital departments, including Emergency, Surgery, Oncology, and Medical Units. Without a dedicated Transfusion Medicine Department, these units cannot operate effectively. Each VAMC needs its own department, as services are site-specific across the VISN. The vendor must keep track of the lot numbers and expiration dates for each reagent provided to the Boise VAMC Blood Bank. Since these reagents are made from cellular material, they expire quickly. The vendor should send the new lot number shortly before the old one expires to ensure the Blood Bank always has the necessary reagents for matching blood products. The vendor shall supply the Transfusion Service with red blood cells reagents that meet the current standards and/or regulations of the Food and Drug Administration (FDA), the College of American Pathologists (CAP), the Joint Commission (TJC), and the American Association of Blood Banks (AABB) to ensure patient safety. | - | Solicitation | 11/18/2026 |
Please see attached Combined Synopsis/Solicitation. See attached estimated quantities and Questions and Answers. | - | Combined Synopsis | 11/18/2026 |
Requesting procurement of a high-throughput FDA approved molecular diagnostic testing system and reagents through a rental purchase agreement. Purchase order is requested to order additional specific products throughout the year necessary to perform rapid syndromic infectious disease diagnostic panels. | - | Market Research | 11/27/2026 |
Additional Details
Solicitation Number
36C24819Q1404
Archive Date
Sep 20, 2019